Completion of this activity will allow learners to discuss the mechanism of delivering radioactive drugs to the tumors based on the Theranostic Nuclear Medicine paradigm; discuss the current treatment options that work according to the Theranostic Nuclear Medicine paradigm; and discuss the optimal applications for Theranostic Nuclear Medicine in clinical practice. This activity is worth 0.75 AOA Category 1A / AMA Category 1 Credits.

Completion of this activity will allow learners to discuss medication and surgical errors, misdiagnoses and system failures; discuss creating a culture of safety, root cause analysis, error reduction and prevention, and patient safety; and review most common errors as defined by the FL-BOOM. This activity is worth 2.0 AOA Category 1A / AMA Category 1 Credits.

Completion of this activity will allow learners to compare and contrast examples of controlled substance schedules and their relevant prescribing limitations; explain the underlying background behind the current opioid epidemic; and describe alternative pharmacologic and non-pharmacologic options for treating pain aside from the use of opioids. This activity is worth 1.75 AOA Category 1A / AMA Category 1 Credits.

Completion of this activity will allow learners to define sex trafficking and labor trafficking; identify individuals who may be victims of human trafficking; and describe how to report cases of human trafficking and provide resources for victims. This activity is worth 0.75 AOA Category 1A / AMA Category 1 Credits.

Completion of this activity will allow learners to identify the issues involving a patient's family member diverting pain medications; develop strategies for addressing unprofessional and unethical behaviors in colleagues and pharmaceutical representatives; recognize patient confidentiality, security of medical records and fiduciary duty of physicians; and recognize the importance of protected communications and health information (HIPAA). This activity is worth 2.50 AOA Category 1A / AMA Category 1 Credits.